spacer
home > ict > autumn 2018 > capturing cancer evidence
PUBLICATIONS
International Clinical Trials

Capturing Cancer Evidence

The Clinical Case

In June 2017, Basch E et al published randomised controlled trials evidence of the benefits of using a digital platform to remotely measure patient-reported outcome measures (PROMs) – clinical assessments that capture the impact of a condition on a patient’s life at a time point – alongside the usual processes of care for patients undergoing chemotherapy for advanced cancer. The study group were found to survive an average of five months longer (which translated to an absolute five-year survival benefit of 8%) than the control group. Additionally, 31% reported quality of life benefits at six months, and emergency room visits were 7% lower (1).

These surprising results were better than those reported by the majority of recently licensed chemotherapy drugs, were more impactful on quality of life, and contributed positively to overall care efficiency and cost effectives.

The reasons for the benefits are because of how the technology allowed the service to better meet the needs of patients. Using remotely collected symptom and outcome data, specialist nurses could monitor patients between appointments and look for treatable problems that may otherwise have escalated and mean patients could no longer tolerate a hospital visit for further doses of chemotherapy, or worse, deteriorate to the point that they are admitted to hospital and deteriorate further.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Tim Williams is the Co-founder and CEO of My Clinical Outcomes – a technology platform that automates the collection and analysis of PROMs in clinical practice. Tim previously worked as an NHS doctor and strategy consultant and has a keen interest in how technology can help improve healthcare services, having also undertaken Professor Michael Porter’s Value-Based Healthcare seminar series at Harvard Business School, US.
spacer
Dr Tim Williams
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PPMA Show 2021 celebrates great success as it leads the way to build back business

The UK’s largest processing and packaging machinery event returned to the NEC, Birmingham (28-30 September) following the cancellation of the 2020 Show. Hailed as a great success by exhibitors and visitors, over 250 exhibitors and 1,250 brands showcased the latest innovations in smart manufacturing, processing equipment and packaging solutions.
More info >>

White Papers

Pandemic respiratory vaccine clinical trials: a departure from business as usual

ICON plc

Around the world, the “V” words are on everyone’s lips: Virus and Vaccines. In response to the urgent need for a vaccine for COVID-19, researchers are, at time of publication, running 500+ clinical trials (and counting) on a number of antivirals, antibodies and vaccines. Promising possibilities range from novel new drugs/vaccines, repurposing treatments currently indicated for HIV, Ebola and malaria, to monoclonal antibodies and immune serum.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement